Saturday, April 20, 2024

Saturday, April 20, 2024

Organization Directory

Refine Your Search Uncategorized Uncategorized S

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 CYTODYN INC.: FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn’s Phase 3 Trial for Severe-to-Critical COVID-19 Patients
  2. 2 AMBRX INC.: FDA Grants ARX788 Fast Track Designation for HER2-positive Metastatic Breast Cancer
  3. 3 GEMINI THERAPEUTICS: Announces FDA Fast Track Designation Granted for GEM103 for the Treatment of Dry Age-Related Macular Degeneration (AMD) in Patients With Complement Factor H (CFH) Loss of Function Gene Variants
FDA Health News